Some great comments here in recent times and agree with all of...

Some great comments here in recent times and agree with all of them. Whilst the dilution is not great, we now have BVF from the US as cornerstone and also Platinum and Aus Ethical. They are all sticky investors and support the company. The US connection will be active and assist promotion. In fact, I believe their book now in the US conference is full. Last year they went and had 1 patient. This year will be ~100 and some interim data. We also now have 2 experienced commercial biotech-preneurs in Brooke and Morstyn. ACW has a full book seeing potential partners.

I've also spoken with management and the selling seems to be largely outside the Top 50, and looks to be day trading. How Aussie speculators can decide to sell at below 5c, where someone like BVF has come in, is fascinatingly crazy. Do they think they no more than specialists!

I agree - the re-rate is coming and won't be very long and a large uplift from here. Despite the extra shares, if Xanamem can prove to assist, even in combination, it will potentially be like a vitamin pill taken daily by the masses to block cortisol in the brain and assist in preventing ALZ. So for sufferers, it may be potentially taken in combination with say Aricept and for those seeking a preventative, we might take it as a daily ritual.

Again if cognitive this will be a blockbuster. Those selling for $0.001 gains below 5c, should not worry about ALZ, but rather about either kicking themselves into oblivion or going to the madhouse!